PHAGENESIS

phagenesis-logo

Phagenesis is developing a device for the treatment for dysphagia, the inability to swallow safely, that often accompanies stroke or other neuro-deficit diseases. The approach is to harness the brain's own capacity for relearning functions that have been lost through brain damage (via "neuroplasticity" or "cortical remapping"). Focusing initially on the care of stroke patients as they recover in hospital (acute care), Prof Shaheen Hamdy of the University of Manchester, UK, painstakingly devised ... a method of delivering electrical signals from the pharynx (throat) along nerve cells directly to the relevant parts of the brain. The results of his work have been published in top peer-reviewed scientific and medical journals, including The Lancet, the Nature group of publications, and Gastroenterology.

#SimilarOrganizations #People #Financial #Website #More

PHAGENESIS

Social Links:

Industry:
Biotechnology Health Care Medical

Founded:
2007-01-01

Address:
Manchester, Manchester, United Kingdom

Country:
United Kingdom

Website Url:
http://www.phagenesis.com

Total Employee:
11+

Status:
Active

Contact:
+44 161 820 4525

Email Addresses:
[email protected]

Total Funding:
29.4 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics


Similar Organizations

soligenix-logo

Soligenix

Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.


Current Advisors List

not_available_image

Fred Edenius Director @ Phagenesis
Board_member
2010-01-01

daniel-green_image

Daniel Green Board of Director @ Phagenesis
Board_member
2010-04-01

oern-stuge_image

Oern Stuge Chairman @ Phagenesis
Board_member
2013-03-01

Current Employees Featured

reinhard-krickl_image

Reinhard Krickl
Reinhard Krickl Chief Executive Officer @ Phagenesis
Chief Executive Officer
2014-01-01

scott-grant_image

Scott Grant
Scott Grant Vice President Therapy Development @ Phagenesis
Vice President Therapy Development
2020-11-01

not_available_image

Tarja Barnes
Tarja Barnes Chief Financial Officer @ Phagenesis
Chief Financial Officer

not_available_image

Rebecca Sheridan
Rebecca Sheridan Head of Quality Assurance and Regulatory Affairs @ Phagenesis
Head of Quality Assurance and Regulatory Affairs

conor-mulrooney_image

Conor Mulrooney
Conor Mulrooney Co-Founder, COO & Board Member @ Phagenesis
Co-Founder, COO & Board Member

not_available_image

Shaheen Hamdy
Shaheen Hamdy Co-Founder, CSO & Board Member @ Phagenesis
Co-Founder, CSO & Board Member

Founder


conor-mulrooney_image

Conor Mulrooney

not_available_image

Shaheen Hamdy

Investors List

medtechinnovator_image

MedTech Innovator

MedTech Innovator investment in Non Equity Assistance - Phagenesis

inventages-venture-capital-investment-inc_image

Inventages Venture Capital Investment Inc.

Inventages Venture Capital Investment Inc. investment in Series B - Phagenesis

inventages-venture-capital-investment-inc_image

Inventages Venture Capital Investment Inc.

Inventages Venture Capital Investment Inc. investment in Series B - Phagenesis

Official Site Inspections

http://www.phagenesis.com Semrush global rank: 7.27 M Semrush visits lastest month: 548

  • Host name: 141.193.213.20
  • IP address: 141.193.213.20
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Phagenesis"

Phagenesis - Dysphagia Therapy Like No Other

Manufacturer; Phagenesis Ltd, Enterprise House, Manchester Science Park, Manchester, M15 6SE, UK. Indications for Use (Europe/UK/Switzerland): The Phagenyx System (EPSB3 Base Station and PNX-1000 catheter) is to be …See details»

About - Phagenesis

Manufacturer; Phagenesis Ltd, Enterprise House, Manchester Science Park, Manchester, M15 6SE, UK. Indications for Use (Europe/UK/Switzerland): The Phagenyx System (EPSB3 Base Station and PNX-1000 catheter) is to be …See details»

Phagenesis - Crunchbase Company Profile & Funding

Phagenesis is developing a device for the treatment for dysphagia, the inability to swallow safely, that often accompanies stroke or other neuro-deficit diseases. …See details»

Phagenesis Ltd - LinkedIn

At Phagenesis, we are dedicated to transforming the way dysphagia is treated. Dysphagia, or difficulty swallowing, can be a debilitating condition that affects millions of people worldwide.See details»

Phagenesis® | National Foundation of Swallowing Disorders

Apr 25, 2023 Please note: The NFOSD is a nonprofit patient advocacy organization. We do not endorse specific products, treatments, or brands. ... in leading various global clinical education …See details»

Phagenesis - EQT Group

Phagenesis. Catheter-based neurostimulation device for treatment of dysphagia (difficulty to swallow). Key Facts. Sector. ... We are eager to explore how we can achieve great things …See details»

Phagenesis 2025 Company Profile: Valuation, Funding & Investors

Phagenesis General Information Description. Developer of a medical device designed to provide treatment of acute dysphagia. The company's device helps harness the brain's capacity for …See details»

Phagenesis - Funding, Financials, Valuation & Investors - Crunchbase

Phagenesis is engaged in the development of a device to treat dysphagia, a condition that disables the safe swallowing of food. New. Resources. Advanced Search. ... How much …See details»

Phagenesis, a medical device company specializing in the …

Mar 4, 2024 Phagenesis® Ltd, is a private MedTech company co-founded by Dr. Conor Mulrooney and Professor Shaheen Hamdy from the University of Manchester in 2007. …See details»

Phagenesis Appoints Chad Hoskins as Chief Executive …

MANCHESTER, England, Sept. 5, 2024 /PRNewswire/ — Phagenesis, a pioneering company that has developed a first-of-its-kind neurostimulation system to treat swallowing dysfunction, today announced the appointment of Chad …See details»

Phagenesis Company Profile - Office Locations, Competitors

Phagenesis is a company that develops a device to treat dysphagia. Its solution provides treatment for the cause of dysphagia which restores the neurological control of swallowing. …See details»

Phagenesis Company Information - Funding, Investors, and More

Phagenesis Series D (2024, $42M) $42m. Similar startup. F2G Seedtable Score 78. MirrorWeb Seedtable Score 78. Peak Seedtable Score 78. Vsim Seedtable Score 78. Classic Football …See details»

Phagenesis Ltd on LinkedIn: Phagenesis raises $42m to take …

Our $42m raise recognises the passion and committment of the Phagenesis Ltd Team who are our most important asset supporting clinicians introducing #Phagenyx. Big thank you to Alyssa …See details»

Phagenesis | National Foundation of Swallowing Disorders

Company Description: Phagenesis is transforming the lives of patients suffering from neurogenic dysphagia using revolutionary treatments developed through a commitment to scientific and …See details»

Phagenesis - VentureRadar

" Phagenesis has developed the first clinically proven treatment for dysphagia, a debilitating and often lethal condition in which the patient's ability to swallow is damaged. Dysphagia can lead …See details»

Phagenesis - Dysphagia Research Society

Phagenesis is innovating the treatment of neurogenic dysphagia. Founded on 25+ years of scientific and clinical research, the Phagenyx® Pharyngeal Electrical Stimulation System …See details»

Phagenesis, a medical device company specializing in the …

Manufacturer; Phagenesis Ltd, Enterprise House, Manchester Science Park, Manchester, M15 6SE, UK. Indications for Use (Europe/UK/Switzerland): The Phagenyx System (EPSB3 Base …See details»

Phagenesis ernennt Chad Hoskins zum Chief Executive Officer …

Manchester, UK – 5. September 2024 – Das britische Pionierunternehmen Phagenesis, das ein neuartiges Neurostimulationssystem zur Behandlung von Schluckstörungen entwickelt hat, …See details»

Build for the User, Not the Spec Sheet: Interview with Phagenesis …

After more than a decade at the helm of Phagenesis, Reinhard Krickl is stepping aside as CEO, setting the stage for the company to spread its wings in the United States. An engineer and an …See details»

Largest real-world study of Phagenyx® demonstrates significant …

Manufacturer; Phagenesis Ltd, Enterprise House, Manchester Science Park, Manchester, M15 6SE, UK. Indications for Use (Europe/UK/Switzerland): The Phagenyx System (EPSB3 Base …See details»

linkstock.net © 2022. All rights reserved